CAS 603139-19-1: Odanacatib
Formula:C25H27F4N3O3S
InChI:InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1
InChI key:InChIKey=FWIVDMJALNEADT-SFTDATJTSA-N
SMILES:N(C([C@@H](N[C@H]([C@](F)(F)F)C1=CC=C(C=C1)C2=CC=C(S(C)(=O)=O)C=C2)CC(C)(C)F)=O)C3(C#N)CC3
Synonyms:- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- N<sup>1</sup>-[(1-Cyanocyclopropyl)-4-fluoro-N<sup>2</sup>-[(1S)-2,2,2-trifluoro-1-[4-methylsulfonyl]-1,1′-biphenyl-4-yl] ethyl]-<span class="text-smallcaps">L</span>-leucinamide
- Odanacatib
- MK 0822
- N1-[(1-Cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-[4-methylsulfonyl]-1,1′-biphenyl-4-yl] ethyl]-L-leucinamide
- Pentanamide, N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)[1,1′-biphenyl]-4-yl]ethyl]amino]-, (2S)-
Sort by
Found 5 products.
MK-0822
CAS:Controlled ProductApplications MK-0822 is a newly developed bone-targeting dual action pro-drug for osteoporosis and bone metastasis. It is also an inhibitor of cathepsin K, an enzyme involved in bone resorption. References Arns, S., et al.: Bioorg. Medn. Chem., 20, 2131 (2012); Cusick, T., et al., J. Bone. Mineral. Rsch., 27, 524 (2013);Formula:C25H27F4N3O3SColor and Shape:Off-WhiteMolecular weight:525.5588MK 0822
CAS:Inhibitor of cathepsin K inhibitor; reduces bone resorptionFormula:C25H27F4N3O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:525.56 g/molOdanacatib
CAS:Odanacatib is an inhibitor of cathepsin K with potential anti-osteoporotic activity.Formula:C25H27F4N3O3SPurity:98.53% - 99.53%Color and Shape:SolidMolecular weight:525.56Ref: TM-T6035
1mg49.00€2mg70.00€5mg105.00€10mg168.00€25mg273.00€50mg410.00€100mg607.00€1mL*10mM (DMSO)118.00€
